NHTC
Natural Health Trends Corp.
NASDAQ · Consumer Cyclical · Specialty Retail · HK
$1.59
−1.85%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 36.0M | 39.8M | 43.0M | 43.9M | 49.1M |
| Cost of Revenue | 9.3M | 10.5M | 11.2M | 11.2M | 12.7M |
| Gross Profit | 26.7M | 29.3M | 31.8M | 32.7M | 36.5M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 25.8M | 31.1M | 33.1M | 34.4M | 36.7M |
| General & Admin Expense | 10.9M | 14.8M | 15.5M | 16.0M | 16.0M |
| Selling & Marketing Expense | 11.7M | 16.3M | 17.6M | 18.4M | 20.7M |
| Other Expenses | 3.1M | — | — | — | — |
| Total Operating Expenses | 28.9M | 31.1M | 33.1M | 34.4M | 36.7M |
| Cost and Expenses | 38.3M | 41.6M | 44.3M | 45.6M | 49.4M |
| Operating Income (EBIT) | (2.2M) | (1.8M) | (1.3M) | (1.7M) | (270.0K) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Net Interest Income | — | — | — | — | — |
| Other Non-Op Income/Expense | 913.0K | 1.2M | 1.9M | 2.4M | 872.0K |
| Non-Operating Income (excl Interest) | (913.0K) | (1.2M) | (1.9M) | (2.4M) | (872.0K) |
| EBT (Pre-Tax Income) | (1.3M) | (567.0K) | 620.0K | 745.0K | 602.0K |
| Income Tax Expense | 290.0K | 315.0K | 48.0K | 177.0K | 289.0K |
| Bottom Line | |||||
| Net Income | (1.6M) | (882.0K) | 572.0K | 568.0K | 313.0K |
| Earnings from Cont. Ops | (1.6M) | (882.0K) | 572.0K | 568.0K | 313.0K |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (1.6M) | (882.0K) | 572.0K | 568.0K | 313.0K |
| Per Share | |||||
| Basic EPS | ($0.15) | ($0.08) | $0.05 | $0.05 | $0.03 |
| Diluted EPS | ($0.15) | ($0.08) | $0.05 | $0.05 | $0.03 |
| Revenue Per Share | $3.85 | $3.46 | $3.75 | $3.84 | $4.32 |
| Shares | |||||
| Basic Shares Outstanding | 9.4M | 11.5M | 11.5M | 11.4M | 11.4M |
| Diluted Shares Outstanding | 9.4M | 11.5M | 11.5M | 11.5M | 11.4M |
| Profitability Metrics | |||||
| EBITDA | (1.3M) | (458.0K) | 751.0K | 909.0K | 806.0K |
| D&A | 62.0K | 109.0K | 131.0K | 164.0K | 204.0K |
| EBIT | (1.3M) | (567.0K) | 620.0K | 745.0K | 602.0K |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026